3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Dermatologic
1
Conditions
Polycystic Ovary Syndrome
3
Fatty Liver
2
Diabetes Mellitus
2
Thyroid Neoplasms
1
Obesity
1
Neoplasms
1
Menstruation Disturbances
1
Lymphoma, T-Cell, Cutaneous
1
Hypertriglyceridemia
1
Hyperthyroidism
1
Graves Disease
1
Glucose Metabolism Disorders
1
Glucose Intolerance
1
Fibrous Dysplasia, Polyostotic
1
Fibrous Dysplasia of Bone
1
Interventions
Cyclophosphamide
41
Peripheral Blood Stem Cell Transplantation
40
fludarabine phosphate
36
Whole-Body Irradiation
27
Mycophenolic Acid
27
Tacrolimus
23
Busulfan
23
Cyclosporine
22
Antilymphocyte Serum
20
Etoposide
17
Methotrexate
16
Filgrastim
16
Melphalan
14
romidepsin
13
Radiotherapy
13
Flow Cytometry
12
Methylprednisolone
10
Brentuximab Vedotin
10
Therapeutics
9
Psychiatric Rehabilitation
9
Lenalidomide
8
pembrolizumab
7
fludarabine
7
Sirolimus
7
Rituximab
7
Bortezomib
7
Bexarotene
7
mogamulizumab
6
Polymerase Chain Reaction
6
Gemcitabine
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Lymphoma, T-Cell, Cutaneous
×
Glucose Tolerance Test
×
Clear all
NCT01569724
2017-07-21
TgBEX
Rennes University Hospital
Phase 4
Completed
10 enrolled